LABU has the worst 1-year decay of this list with a drift of -13.56%. Over the last 12 months, the return of LABU (15.77%) is inferior to the return of the non-leveraged biotech index (18.82% ...

LABU - Direxion Daily Biotech Bull 3X Shares ETF. Fund Details. Fund Type Miscellaneous. Issuer Direxion Funds. Inception 05/28/2015. Expense Ratio 1.01%. AUM $1.23B # of Holdings 145 *Holdings as ...

Learn more about the Direxion Daily S&P Biotech Bull 3X exchange traded fund, a triple-leveraged ETF tracking biotechnology equities.

Although LABU is already up almost 46 percent this month, the ETF remains appealing on a technical basis, indicating it could deliver more near-term upside for risk-tolerant traders.

LABU fell to the $5.97 flat lower trendline but collapsed through March 2023 as shares reached a new swing low of $4.57. Pullback support levels are at $4.57, $4.06, $3.40, and $2.52.

Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the DIREXION DAILY STANDARD AND POORS BIOTECH BULL 3X SHARES (LABU ...